Claims for Patent: 8,562,983

Summary for Patent: 8,562,983

Title:	System comprising elastase
Abstract:	The invention provides systems for treating an obstructed biological conduit that include administering to the conduit an agent that can degrade extracellular matrix of obstructing tissue. Particular methods include delivery of an enzyme or a mixture of several enzymes to the area or region of obstruction wherein the enzyme(s) have the capability to degrade extracellular matrix components within the obstruction thereby restoring the normal flow of transported fluid through the conduit. The invention also includes prophylactically dilating a section of conduit to minimize the risk of obstruction formation.
Inventor(s):	Franano; F. Nicholas (Kansas City, MO)
Assignee:	Proteon Therapeutics, Inc. (Waltham, MA)
Application Number:	12/229,428
Patent Claims:	1. A system for enlarging the diameter of an artery in a human subject, said artery having a lumen, the system comprising: (a) a catheter configured for injecting a pharmaceutical composition directly into a selected segment of the wall of the artery; and (b) a pharmaceutical composition suitable for administration to the human subject comprising an elastase, wherein said elastase is present in a dose sufficient to enlarge the diameter of the artery and the diameter of the lumen of the artery when administered via the catheter to the wall of the artery in the human subject. 2. A system for enlarging the diameter of a vein in a human subject, said vein having a lumen, the system comprising:. (a) a catheter configured for injecting a pharmaceutical composition directly into a selected segment of the wall of the vein; and (b) a pharmaceutical composition suitable for administration to the human subject comprising an elastase, wherein said elastase is present in a dose sufficient to enlarge the diameter of the vein and the diameter of the lumen of the vein when administered via the catheter to the wall of the vein in the human subject. 3. The system of claim 1 or 2, wherein the catheter comprises a channel for delivery of said pharmaceutical composition. 4. The system of claim 3, wherein a delivery device containing the pharmaceutical composition is connected to the catheter for delivering the pharmaceutical composition to the artery or vein via the channel. 5. The system of claim 4, wherein the delivery device is a syringe. 6. The system of claim 1 or 2, which is configured for delivering the pharmaceutical composition at low pressure into the wall of the artery or vein. 7. The system of claim 1 or 2, wherein the catheter comprises at least one injector port configured for entering the wall of the artery or vein and injecting the pharmaceutical composition directly into the wall of the artery or vein. 8. The system of claim 7, wherein said at least one injector port is mounted on the surface of one or more inflatable balloons. 9. The system of claim 1 or 2, wherein the elastase is a pancreatic elastase. 10. The system of claim 1 or 2, wherein the pharmaceutical composition does not comprise a collagenase. 11. The system of claim 1 or 2, wherein the catheter comprises a plurality of injector ports configured for injecting the pharmaceutical composition directly into the wall of the artery or vein 12. The system of claim 11, wherein said injector ports can be extended so as to enter the wall of the artery or vein. 13. . The system of claim 11, wherein said injector ports are mounted on the surface of one or more inflatable balloons. 14. The system of claim 1 or 2, wherein the catheter comprises a reservoir containing the elastase composition.

Details for Patent 8,562,983

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2019-09-24